Cassava Sciences (SAVA) is not considered a strong buy, as indicated by the consensus rating and price target set by analysts.
- Consensus Rating: The consensus rating for SAVA is a "Moderate Buy" based on the analysis of 3 analysts giving stock ratings to Cassava Sciences in the past 3 months1.
- Average Price Target: The average price target for SAVA is $21.40, with a high forecast of $107.00 and a low forecast of $14.92. This represents a potential upside, but the high and low price targets vary significantly, indicating uncertainty among analysts12.
- Analyst Confidence: The moderate buy rating and the wide range of price targets suggest that analysts have a mixed view of the company's future performance. While some analysts are optimistic about the company's potential, others are more cautious, which could be due to factors such as the company's financial performance, legal challenges, or valuation uncertainties32.
Given these points, it is clear that Cassava Sciences is not considered a strong buy based on analyst ratings and price targets.